Rocket Pharmaceuticals, Inc.
RCKTNasdaqCIK 1281895HealthcareFiscal year ends Dec 31
Reports and events: 238 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0617:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038818 |
| 2026-09-1507:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036563 |
| 2026-08-2716:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-034689 |
| 2026-08-1016:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032028 |
| 2026-08-1016:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342348 |
| 2026-08-0307:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-030568 |
| 2026-06-3017:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-026982 |
| 2026-06-1207:10 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-024997 |
| 2026-05-2106:02 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-022311 |
| 2026-05-0716:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019573 |
| 2026-05-0716:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211873 |
| 2026-04-2807:34 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-017275 |
| 2026-04-0616:06 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001140361-26-013335 |
| 2026-03-2707:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-011573 |
| 2026-03-1017:24 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-008853 |
| 2026-02-2616:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-006981 |
| 2026-02-2616:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076551 |
| 2025-11-0616:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269474 |
| 2025-11-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-040774 |
| 2025-10-1407:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-038030 |
| 2025-10-0316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-037237 |
| 2025-10-0307:02 ET | 8-K | 8.01 Other events | 0001140361-25-037163 |
| 2025-09-2917:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-036556 |
| 2025-09-1716:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-035251 |
| 2025-08-2516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-032502 |
| 2025-08-2007:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032012 |
| 2025-08-0716:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104996 |
| 2025-08-0716:02 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-029582 |
| 2025-07-2407:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-027032 |
| 2025-07-2316:29 ET | 8-K | 2.05 Exit or disposal costs | 0001140361-25-026946 |
| 2025-07-1707:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-026132 |
| 2025-07-1116:38 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-025673 |
| 2025-06-1816:52 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-022996 |
| 2025-05-2707:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-020409 |
| 2025-05-1516:57 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-019326 |
| 2025-05-0816:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017958 |
| 2025-05-0816:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066898 |
| 2025-04-3016:14 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001140361-25-016656 |
| 2025-04-2916:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-016338 |
| 2025-04-0717:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-012621 |
| 2025-02-2716:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-006302 |
| 2025-02-2716:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029002 |
| 2025-01-2821:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-002103 |
| 2024-12-1619:51 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-279899 |
| 2024-12-1216:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-049137 |
| 2024-12-0516:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-24-048475 |
| 2024-11-1816:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-047166 |
| 2024-11-0716:45 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123459 |
| 2024-11-0716:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-045670 |
| 2024-09-1116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-24-040837 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:58 ET. Listed shows no prices and gives no investment advice.